期刊文献+

Stevens-Johnson综合征慢性期结膜中Fas-FasL的表达 被引量:3

Conjunctival Fas-FasL expression in chronic Stevens-Johnson syndrome
原文传递
导出
摘要 目的 探讨Fas-FasL通路在Stevens-Johnson综合征(SjS)患者慢性期眼部病变病理机制中的作用.方法 回顾性研究.收集SJS慢性期存在眼部病变的患者14例,在睑球粘连松解术中取结膜组织,病理切片下观察形态学特点,采用免疫组织化学方法(直接免疫荧光染色)评估患者结膜组织中Fas-FasL(CD95/CD178)的表达,并与正常结膜进行对照.结果 结膜组织病理切片可见上皮层增厚和上皮层下空洞样黏液腺泡破坏,SJS组Fas表达多分布于上皮基底层;正常结膜标本Fas表达高于SJS组,在整个上皮层内均匀分布.FasL在SJS组和正常对照组结膜中均微弱表达.结论 SJS患者慢性期结膜组织中Fas-FasL的局部低表达在产生SJS慢性期患者眼部损伤中起到一定的作用. Objective To investigate the expression level of Fas-FasL in conjunctiva tissue of chronic Stevens-Johnson syndrome (SJS) patients and to analyze the role of Fas-FasL pathway in the mechanism of ocular damage related to SJS.Methods Conjunctiva tissue was obtained during symblepharon release operation and cryostat sectioned at 5 μm.The tissue morphology was observed by electron microscopy.The expression of Fas-FasL (CD95/CD178) in conjunctiva was detected by immunohistochemistry (direct immunofluorescence).The conjunctiva tissue of normal people was also observed and tested as contrast group.Results The pathogenic changes included incrassation of epithelium and cavity of mucous glands in the sub-epithelium.The expression of Fas in SJS patients focusing in the basal layer of epithelium appeared a lower level compared to that in normal human conjunctiva,which distributed equally in all layers of epithelium.The expressions of FasL in SJS patients and normal people were both weak.Conclusions The low level expression of Fas-FasL in conjunctiva of SJS patients has certain effect on the chronic ocular damage.
出处 《中华眼科杂志》 CAS CSCD 北大核心 2014年第9期691-694,共4页 Chinese Journal of Ophthalmology
基金 国家自然科学基金(81170826)
关键词 STEVENS-JOHNSON综合征 直接免疫荧光 Fas-FasL Stevens-Johnson syndrome Fas-FasL Direct immunofluorescence
  • 相关文献

参考文献15

  • 1Chang YS,Huang FC,Tseng SH,et al.Erythema multiforme,Stevens-Johnson syndrome,and toxic epidermal necrolysis:acute ocular manifestations,causes,and management[J].Cornea,2007,26:123-129.
  • 2Chung WH,Hung SI,Hong HS,et al.Medical genetics:a marker for Stevens-Johnson syndrome[J].Nature,2004,428:486.
  • 3Power WJ.Ghoraishi M,Merayo-Lloves J,et al.Analysis of the acute ophthalmic manifestations of the erythema multiforme/Stevens-Johnson syndrome/toxic epidermal necrolysis disease spectrum[J].Ophthahmology,1995,102:1669-1676.
  • 4Wilkins J,Morrison L,White CR Jr.Oculocutaneous manifestations of the erythema multiforme/Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum[J].Dermatol Clin,1992,10:571-582.
  • 5Wu J,Metz C,Xu X,Abe R,et al.A novel polymorphic CAAT/ enhancer-binding protein beta element in the FasL gene promoter alters Fas ligand expression:a candidate background gene in African American systemic lupus erythematosus patients[J].J Immunol,2003,170:132-138.
  • 6Sun T,Zhou Y,Li H,et al.FASL-844C polymorphism is associated with increased activation-induced T cell death and risk of cervical cancer[J].J Exp Med,2005,202:967-974.
  • 7Nassif A,Bensussan A,Dorothée G,et al.Drug specific cytotoxic T-cells in the skin lesions of a patient with toxic epidermal necrolysis[J].J Invest Dermatol,2002,118:728-733.
  • 8Murata J,Abe R,Shimizu H.Increased soluble Fas ligand levels in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis preceding skin detachment[J].J Allergy Clin Immunol,2008,122:992-1000.
  • 9Abe R.Toxic epidermal necrolysis and Stevens-Johnson syndrome:soluble Fas ligand involvement in the pathomechanisms of these diseases[J].J Dermatol Sci,2008,52:151-159.
  • 10Viard I,Wehrli P,Bullani R,et al.Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin[J].Science,1998,282:490-493.

同被引文献17

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部